Vasopressin, hypothalamo-neurohypophyseal system and aging

Archives of Gerontology and Geriatrics

Volumn 29, Issue 3, 2000, Pages 193-214

  Frolkis, Vladimir V ^a   Kvitnitskaya Ryzhova, Tatiana Yu ^a   Dubiley, Tatiana A ^a  

^a INSTITUTE OF GERONTOLOGY   (Ukraine)

Author keywords

Aging; Hypothalamic neurohypophyseal system; Vasopressin

Indexed keywords

VASOPRESSIN;

AGING; ARTICLE; EMOTIONAL STRESS; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; KARYOMETRY; MONOAMINERGIC SYSTEM; NEUROSECRETORY CELL; NONHUMAN; PRIORITY JOURNAL; VASOPRESSIN BLOOD LEVEL; WATER DEPRIVATION;

EID: 0033990676     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4943(99)00032-1     Document Type: Article

References (78)

1. Aravich P.F., Sladek J.R. Aging and rodent vasopressin systems. Morphometric and functional considerations. Gash D.M., Boer G.J. Vasopressin: Principles and Properties. 1987;579-610 Plenum, New York.
2. Arnauld E., Cirino M., Layton B.S., Renaud L.P. Contrasting actions of amino acids, acetylcholine, noradrenaline and leucine enkephalin on the excitability of supraoptic vasopressin-secreting neurons. Neuroendocrinology. 36:1983;187-196.
3. Arora A.S., Forsling M.L., Jenkins D.P., Peysner K. A comparison of the effects of ageing on fluid balance and vasopressin metabolism in the male and female rat. J. Physiol. (UK). 34:1987;42.
4. Bezrukov V.V. Hypothalamus in aging. Physiological Mechanisms of Aging. 1982;94-106 Nauka, pp, Leningrad. (in Russian).
5. Bezrukov V.V. Effects of adrenalin, insulin and estradioldipropionate on electrical activity and excitability of hypothalamic nuclei in animals of different age. J. Physiol. (Ukr.). 30:1984;85-90. (in Russian).
6. Boer G.J., Swaab D.F., Uylings H.B.M., Boer K., Buijs R.M., Velis D.N. Neuropeptides in the rat brain development. Progr. Brain Res. 53:1980;207-227.
7. Brooks D.P., Share L., Crofton J.T. Central adrenergic control of vasopressin release. Neuroendocrinology. 42:1986;416-420.
8. Brownfield M.S., Greathouse J., Lorens S.A., Armstrong J., Urban J., Van de Kar L.D. Neuropharmacological characterization of serotoninergic stimulation of vasopressin secretion in conscious rats. Neuroendocrinology. 42:1986;416-420.
9. Buijs R.M., De Vries G.J., Van Leeuwen F.W., Swaab D.F. Vasopressin and oxytocin: distribution and putative functions in the brain. Progr. Brain Res. 60:1983;101-122.
10. Calza L., Giardino L., Velardo A., Battistini N., Marrama P. Influence of aging on the neurochemical organization of the rat paraventricular nucleus. J. Chem. Neuroanat. 3:1990;215-231.
11. Cizza G., Calogero A.E., Brady L.S., Bagdy G., Bergamini E., Blackman M.R., Chrousos G.P., Gold P.W. Male Fisher 344/N rats show a progressive central impairment of the hypothalamic-pituitary-adrenal axis with advancing age. Endocrinology. 134:1994;1611-1620.
12. Coleman R.J., Reppert S.M. CSF vasopressin rhythm is effectively insulated from osmotic regulation of plasma vasopressin. Am. J. Physiol. 248:1985;E346-E352.
13. Crespo D., Fernandez-Viadero C., Gonzalez C. The influence of age on supraoptic nucleus neurons of the rat: morphometric and morphologic changes. Mech. Ageing Dev. 62:1992;223-228.
14. Davies I., Fotheringham A.P. The influence of age on the hypothalamo-neurohypophyseal system of the mouse: a quantitative ultrastructural analysis of the supraoptic nucleus. Mech. Ageing Dev. 12:1980;93-105.
15. Davies I., Fotheringham A.P., Roberts C. Lipofuscin in the aging hypothalamo-neurohypophysial system. Arch. Biol. (Belg.). 96:1985;344.
16. Delanoy R.L., Krammarcy N.R., Dunn A.J. ACTH 1-24 and lysine vasopressin selectively activate dopamine synthesis in frontal cortex. Brain Res. 231:1982;117-129.
17. De Novellis V., Filippelli A., Loffreda A., Rossi F. Vasomotor reactivity and catecholamine, arginine vasopressin plasma levels during aging and development in rats. Mech. Ageing Dev. 77:1994;55-66.
18. Doris P.A., Bell F.R. Vasopressin in plasma and cerebrospinal fluid of hydrated and dehydrated steers. Neuroendocrinology. 38:1984;290-296.
19. Dorsa D.M., Bottemiller L. Age-related changes of vasopressin content of microdissected areas of the brain. Brain Res. 242:1982;151-156.
20. Duggan J., Kilfeather S., Lightman S.L., O'Malley K. The association of age with plasma arginine vasopressin and plasma osmolality. Age Ageing. 22:1993;332-336.
21. Faull C.M., Holmes C., Baylis P.H. Water balance in elderly people: is there a deficiency of vasopressin? Age Ageing. 22:1993;114-120.
22. Fliers E., Swaab D.F. Activation of vasopressinergic and oxytocinergic neurons during aging in the Wistar rat. Peptides. 4:1983;165-170.
23. Flood D.G., Coleman P.D. Dendritic regression dissociated from neuronal death but associated with partial deafferentation in aging rat supraoptic nucleus. Neurobiol. Aging. 14:1993;575-587.
24. Fotheringham A.P., Davidson Y.S., Davies I., Morris J.A. Ageassociated changes in neuroaxonal transport in the hypothalamo-neurohypophysial system of the mouse. Mech. Ageing Dev. 60:1991;113-121.
25. Frolkis, V.V., 1983. The role of vasopressin in regulation of cardiovascular system functions in aging and in development of its pathology. In: Chebotarev, D.F., Frolkis, V.V. (Eds.), The Issues of Gerontology, 5. Vasopressin and Pathology of the Cardiovascular System in Aging. Institute of Gerontology, Kiev, pp.77-86 (in Russian).
26. Frolkis V.V. Stress-age syndrome. Mech. Ageing Dev. 63:1993;93-108.
27. Frolkis V.V., Golovchenko S.F., Medved V.I., Frolkis R.A. Vasopressin and cardiovascular system in aging. Gerontology (Schweiz). 28:1982;290-302.
28. Frolkis V.V., Bezrukov V.V., Kulchitsky O.K. The Aging Cardiovascular System: Physiology and Pathology. 1996;238 Springer Publishing Company, New York.
29. Gordiyenko, V.M., Ivanova, L.S., Garmatina, S.M., 1989. Peculiarities of structural rearrangements in magnocellular hypothalamic nuclei in aging. Problems of Hypothalamus Physiology. Issue 23. Vyshcha Shkola Publisher, Kiev, pp. 72-77 (in Russian).
30. Goudsmit, E., Swaab, D.F., 1989. Neuroendocrine aspects of normal and pathological aging. Recent Adv. Basic Clin. Neuroendocrinol.: Proc. 4th Meeting Eur. Neuroendocr. Assoc., Santiago de Compostela, 20-30 June 1989. Amsterdam, pp. 369-382.
31. Goudsmit E., Fliers E., Swaab D.F. Vasopressin and oxytocin excretion in the Brown-Norway rat in relation to ageing, water metabolism and testosterone. Mech. Ageing Dev. 44:1988;241-252.
32. Higuchi T., Honda K., Takano S., Negoro H., Kawashima S. Increased plasma concentrations and decreased releasability of oxytocin and vasopressin in aged Wistar/TW rats. Neuroendocrinology. 52(Suppl. N1):1990;115.
33. Hillhouse E.W., Milton N.G.N. Effect of acetylcholine and 5-hydroxytryptamine on the secretion of CRF-41 and arginine vasopressin from the rat hypothalamus in vitro. J. Endocrinol. 122:1989;713-718.
34. Hofman M.A., Goudsmit E., Purba J.S., Swaab D.F. Morphometric analysis of the supraoptic nucleus in the human brain. J. Anat. 172:1990;259-270.
35. Iovino M., Steardo L. Effect of substances influencing brain serotonergic transmission on plasma vasopressin levels in the rat. Eur. J. Pharmacol. 113:1985;99-103.
36. Johnson A.G., Crawford G.A., Kelly D., Nguyen T.V., Gyory A.Z. Arginine vasopressin and osmolality in the elderly. J. Am. Geriatr. Soc. 42:1994;399-404.
37. Jolkkonen J. Vasopressin in the Central Nervous System. A Study Based on Cerebrospinal Fluid Measurements. 1988;54 University of Kuopio, Kuopio.
38. Jolkkonen J., Tuomisto L., van Wimersma Greidanus Tj.B., Laara E., Riekkinen P.J. Effects of osmotic stimuli on vasopressin levels in the CSF of rats. Peptides. 9(Suppl. 1):1988;109-111.
39. Kawashima S., Kawamoto K. Age-related changes in plasticity of vasopressin- and oxytocin-immunoreactive neurons in rats and mice. Pepeu G., Tomlinson B., Wischik C.M. New Trends in Aging Reseach. Fidia Research Series,15. 1988;67-74 Liviana Press, Springer Verlag, Padova.
40. Kawashima S., Kawamoto K., Kobayashi Y. Aging of the hypothalamo-neurohypophysial system and water metabolism in rats. Zool. Sci. 3:1986;227-244.
41. Kimura T., Share L., Wang B.C., Crofton J. Central effects of dopamine and bromocriptine on vasopressin release and blood pressure. Neuroendocrinology. 33:1981;347-351.
42. Kvitnitskaya-Ryzhova T.Yu., Magdich L.V. Vasopressin concentration in the cerebrospinal fluid and some structural parameters of the hypothalamic-neurohypophysial system in aging and stress. Bull. Exp. Biol. Med. 116:1993;42-44. (in Russian).
43. Landgraf R., Gunter O. Vasopressin and oxytocin in cerebrospinal fluid and plasma of conscious rabbits-response to dehydration and haemorrhage. Biomed. Biochim. Acta. 42:1983;1339-1341.
44. Lin K.H., Peng Y.M., Peng M.T., Tseng T.M. Changes in the nuclear volume of rat hypothalamic neurons in old age. Neuroendocrinology. 21:1970;247-254.
45. Lolova I.S. Vasopressin- and oxytocin-immunoreactive nerve cells in the aging rat hypothalamus. Acta Physiol. Pharmacol. Bulg. 22:1996;7-16.
46. Lucassen P.J., Salehi A., Pool C.W., Gonatas N.K., Swaab D.F. Activation of vasopressin neurons in aging and Alzheimer's disease. J. Neuroendocrinol. 6:1994;673-679.
47. Lucassen P.J., Van Heerikhuize J.J., Guldenaar S.E., Pool C.W., Hofman M.A., Swaab D.F. Unchanched amount of vasopressin mRNA in the supraoptic and paraventricular nucleus during aging in Alzheimer's disease. J. Neuroendocrinol. 9:1997;297-305.
48. Mazurek M.F., Beal F.M., Bird E.D., Martin J.B. Vasopressin in Alzheimer's disease: a study of postmortem brain concentrations. Ann. Neurol. 20:1996;665-670.
49. Mens W.B.J., Bouman H.J., Bakker E.A.D., van Wimersma Greidanus Tj.B. Differential effects of various stimuli on AVP levels in blood and cerebrospinal fluid. Eur. J. Pharmacol. 68:1980;89-92.
50. Miller M. Increased vasopressin secretion: an early manifestation of aging in the rat. J. Gerontol. 42:1987;3-7.
51. Moos F., Richard P. Excitatory effect of dopamine on oxytocin and vasopressin reflex releases in the rat. Brain Res. 241:1982;249-260.
52. Peng M.T., Hsu H.K. No neuron loss from hypothalamic nuclei of old male rats. Gerontology (Schweiz). 28:1982;19-22.
53. Polenov, A.L., Abelson, Yu.O., Arutyunyan, N.A. et al., 1993. Neuroendocrinology. In: Polenov, A.L. (Ed.), Basic Problems of Modern Physiology. Russian Academy of Sciences, St.Petersburg, 399 pp. (in Russian).
54. Rabhi M. Development of the hypothalamic vasopressin system and nephrons in Meriones shawi during ontogenesis. Anat. Embryol. 193:1996;281-296.
55. Racke K., Ritzel H., Trapp B., Muscholl E. Dopaminergic modulation of evoked vasopressin release from the isolated neurohypophysis of the rat. Possible involvement of endogenous opioids. Naunyn-Schmiedebergs Arch. Pharmak. 319:1982;56-65.
56. Ravid R., Fliers E., Swaab D.F., Zurcher C. Changes in vasopressin and testosterone in the senescent Brown-Norway (BN/BiRij) rat. Gerontology (Schweiz). 33:1987;87-98.
57. Rogers J., Bloom F.E. Neurotransmitter metabolism and function in the aging central nervous system. Finch C.E., Schneider E.L. Handbook of the Biology of Aging. second edition:1985;591-645 Van Nostrand Reinhold, New York.
58. Sartin J.L., Lamperti A.A. Neuron numbers in hypothalamic nuclei of young, middle-aged and aged male rats. Experientia. 41:1985;109-111.
59. Schwarzberg H., Kovacs G.L., Szabo G., Telegdy G. Intraventricular administration of vasopressin and oxytocin effects the steady-state levels of serotonin, dopamine and norepinephrine in rat brain. Endocrinolog. Exp. 15:1981;75-80.
60. Silverman W.F., Sladek J.R. Ultrastructural changes in magnocellular neurons from the supraoptic nucleus of aged rats. Brain Res. Dev. Brain Res. 58:1991;25-34.
61. Silverman W.F., Aravich P.A., Sladek J.R., Sladek C.D. Physiological and biochemical indices of neurohypophyseal function in the aging Fischer rat. Neuroendocrinology. 52:1990;181-190.
62. Sladek C.D., Olschowska J.A. Dehydratation induces Fos, but not increased vasopressin mRNA in the supraoptic nucleus of aged rats. Brain Res. 652:1994;207-215.
63. Sladek C.D., McNeill T.H., Gregg C.M., Blair M.L., Baggs R.B. Vasopressin and renine response to dehydration in aged rats. Neurobiol. Aging. 2:1981;293-302.
64. Sladek J.R., Scholer J., Armstrong W.E. Norepinephrine-vasopressin interactions during aging. Sano Y., Ibata Y., Zimmerman H. Structure and Function of Peptidergic and Aminergic Neurons. 1983;289-298 Japan Sci. Soc. Press, Tokyo.
65. Sturrock R.R. Stability of neuron number in the ageing mouse paraventricular nucleus. Anat. Anz. 174:1992;337-340.
66. Szczepanska-Sadowska E., Gray D., Simon-Oppermann C. Vasopressin in blood and third ventricle CSF during dehydratation, thirst and hemorrhage. Am. J. Physiol. 245(14):1983;R549-R555.
67. Swaab D.F. Ageing of the human hypothalamus. Hormone Res. 43:1995;8-11.
68. Swaab D.F., Fliers E., Hoogendijk J.E. Vasopressin in relation to human aging and dementia. Gash D.M., Boer G.J. Vasopressin: Principles and Properties. 1987;611-625 Plenum, New York.
69. Terwel D., Jolles J. The relationship between plasma osmolality and plasma vasopressin concentration is altered in old male Lewis rats. Eur. J. Endocrinol. 131:1994;86-90.
70. Terwel D., Markerink M., Jolles J. Age-related changes in concentrations of vasopressin in the central nervous system and plasma of the male Wistar rat. Mech. Ageing Dev. 65:1992;127-136.
71. Ugryumov M.V. Neuroendocrine Regulation in Ontogeneses. 1989;248 Nauka, Moscow. (in Russian).
72. Van der Woude P.F., Goudsmit E., Wierda M., Purba J.S., Hofman M.A., Bogte H., Swaab D.F. No vasopressin cell loss in the human hypothalamus in aging and Alzheimer's disease. Neurobiol. Aging. 16:1995;11-18.
73. Van Zuveiten E.J., Kos W.T., Ravid R., Swaab D.F. Decreased number of vasopressin immunoreactive neurons in the medial amygdala and locus coeruleus of aged rats. Neurobiol. Aging. 14:1993;245-248.
74. Verkhratsky, N.S., Golovchenko, S.F., Kvitnitskaya-Ryzhova, T.Y., Magdich, L.V., Didenko, S.O., 1983. Vasopressin and stress. In: Chebotarev, D.F., Frolkis, V.V. (Eds.), Questions of Gerontology, 5. Vasopressin and Pathology of the Cardiovascular System in Aging. Institution of Gerontology, Kiev, pp. 32-38 (in Russian).
75. Wierda M., Goudsmit E., Van der Woude P.F., Purba J.S., Hofman M.A., Bogte H., Swaab D.F. Oxytocin cell number in the human paraventricular nucleus remains constant with aging and in Alzheimer's disease. Neurobiol. Aging. 12:1991;511-516.
76. Zbuzek V., Zbuzek V.K. Vasopressin and aging. Interdiscipl. Topics Gerontol. 24:1988;125-133.
77. Zbuzek V.K., Zbuzek V., Wu W. The effect of aging on vasopressin system in Fisher 344 rats. Exp. Gerontol. 18:1983;305-311.
78. Zhukova, S.V., Manzheley, E.S., Milayeva, S.Ya., 1987. Age-related peculiarities of supraoptic hypothalmic nuclei neuro-secretory activity of the rats under dehydration conditions. Mechanisms of Ontogenesis and its Regulation, Zdorovya Publisher, Kiev, pp. 145-147 (in Russian).